BioForce Nanosciences Holdings, Inc. (BFNH)
OTCMKTS · Delayed Price · Currency is USD
4.092
+0.442 (12.11%)
At close: Sep 1, 2026

BFNH Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
000000.01
Cash & Short-Term Investments
000000.01
Cash Growth
-66.08%-8.82%35.11%-13.08%-93.39%-72.14%
Prepaid Expenses
2.15----0
Total Current Assets
2.1500000.01
Total Assets
2.3900000.01

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
0.010.010.01000.01
Accrued Expenses
0.020.512.021.61.170.75
Short-Term Debt
-0.10.270.220.170.12
Other Current Liabilities
0.05-----
Total Current Liabilities
0.080.622.31.821.350.87
Total Liabilities
0.080.622.31.821.350.87

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.030.030.030.030.030.03
Additional Paid-In Capital
162.06161.76158.79158.78158.78158.78
Retained Earnings
-162.28-162.41-161.12-160.63-160.16-159.67
Shareholders' Equity
2.3-0.62-2.3-1.82-1.35-0.86
Total Liabilities & Equity
2.3900000.01

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
-0.10.270.220.170.12
Net Cash (Debt)
0-0.1-0.27-0.22-0.17-0.11
Net Cash Growth
------
Net Cash Per Share
0.00-0.00-0.01-0.01-0.01-0.00
Filing Date Shares Outstanding
33.5533.5233.5229.2729.2729.27
Total Common Shares Outstanding
33.5533.5229.2729.2729.2729.27
Working Capital
2.07-0.62-2.3-1.82-1.35-0.86
Book Value Per Share
0.07-0.02-0.08-0.06-0.05-0.03
Tangible Book Value
2.3-0.62-2.3-1.82-1.35-0.86
Tangible Book Value Per Share
0.07-0.02-0.08-0.06-0.05-0.03